Forma Therapeutics Holdings, Inc. announced unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2020. For the quarter, the company reported loss from operations was $32,807,000 against $26,039,000 a year ago. Net loss was $28,588,000 against $24,656,000 a year ago. Basic net loss per share of common stock was $0.68 against $11.31 a year ago. Diluted net loss per share of common stock was $0.68 against $11.48 a year ago. For the full year, the company reported loss from operations was $124,212,000 against $40,450,000 a year ago. Net loss was $70,414,000 against $34,793,000 a year ago. Basic net loss per share of common stock was $3.22 against $20.70 a year ago. Diluted net loss per share of common stock was $3.22 against $21.08 a year ago.